TN8.SG - Thermo Fisher Scientific Inc. R

Stuttgart - Stuttgart Delayed Price. Currency in EUR
162.06
-0.18 (-0.11%)
As of 8:05AM CET. Market open.
Stock chart is not supported by your current browser
Previous Close162.24
Open162.06
Bid162.17 x 100000
Ask162.84 x 100000
Day's Range162.06 - 162.06
52 Week Range130.18 - 173.78
Volume0
Avg. Volume21
Market CapN/A
BetaN/A
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • GlobeNewswire15 days ago

    Research Report Identifies Wal-Mart Stores, Square, Thermo Fisher Scientific, Sanchez Energy, Urban Outfitters, and TRI Pointe Group with Renewed Outlook — Fundamental Analysis, Calculating Forward Movement

    NEW YORK, Nov. 29, 2017-- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors, traders, and shareholders of ...

  • Thermo Fisher Scientific Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Corporation
    PR Newswire22 days ago

    Thermo Fisher Scientific Recommends Shareholders Reject Mini-Tender Offer by TRC Capital Corporation

    WALTHAM, Mass., Nov. 21, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, today announced that it received notice of an unsolicited "mini-tender" offer by TRC Capital Corporation (TRC) to purchase up to 1,000,000 shares of Thermo Fisher's common stock at a price of $181.75 per share in cash. TRC's offer price is approximately 4.43% lower than the $190.17 closing price of Thermo Fisher's common stock on November 17, 2017, the last closing price prior to commencement of the offer. The offer is for approximately 0.249% of Thermo Fisher's outstanding shares of common stock as of the offer date.

  • Thermo Fisher Scientific Declares Quarterly Dividend
    PR Newswirelast month

    Thermo Fisher Scientific Declares Quarterly Dividend

    WALTHAM, Mass. , Nov. 9, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today announced that its board of directors declared a quarterly cash dividend ...

  • ACCESSWIRElast month

    Featured Company News - Quest Diagnostics Acquires California Laboratory Associates

    Research Desk Line-up: Thermo Fisher Scientific Post Earnings Coverage LONDON, UK / ACCESSWIRE / November 1, 2017 / Pro-Trader Daily takes a look at the latest corporate events and news making the headlines ...

  • Benzingalast month

    Buy Thermo Fisher On Amazon Fear-Inspired Dip

    Shares of Thermo Fisher Scientific Inc. (NYSE: TMO ) came under heavy selling pressure last Friday, which continued into Monday's trading session amid ongoing concerns that Amazon.com, Inc. (NASDAQ: AMZN ...

  • Thermo Fisher Scientific to Present at the Baird 2017 Global Industrial Conference on November 7, 2017
    PR Newswirelast month

    Thermo Fisher Scientific to Present at the Baird 2017 Global Industrial Conference on November 7, 2017

    WALTHAM, Mass. , Oct. 30, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper , president and chief executive officer, will ...

  • GlobeNewswire2 months ago

    New Research Coverage Highlights Cigna, Thermo Fisher Scientific, Raytheon, W. W. Grainger, Waters, and Cummins – Consolidated Revenues, Company Growth, and Expectations for 2018

    NEW YORK, Oct. 26, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Cigna ...

  • American City Business Journals2 months ago

    Thermo Fisher, Boston Scientific work to restart Puerto Rico operations after hurricane

    Thermo Fisher Scientific and Boston Scientific, the state’s largest medical device and scientific equipment companies, say they are still grappling with the aftermath of Hurricane Maria, which knocked out power on most of the island. Like many other device firms nationally, Waltham-based Thermo Fisher (TMO) and Marlborough-based Boston Scientific (BSX) each have facilities in Puerto Rico due in part to the U.S. territory’s favorable corporate tax climate. With 75 percent of the island still without power and 25 percent without water as of Wednesday — more than a month after Maria made landfall — the industry has been working closely with the FDA to get facilities back online in an effort to prevent shortages of critical products.

  • Reuters2 months ago

    Thermo Fisher tops profit estimates; raises full-year forecast

    Thermo Fisher Scientific Inc, the world's largest maker of scientific instruments, on Wednesday reported a higher-than-expected quarterly profit, fueled by sales growth in all of its units and contributions ...

  • Associated Press2 months ago

    Thermo Fisher beats Street 3Q forecasts

    The Waltham, Massachusetts-based company said it had profit of $1.34 per share. Earnings, adjusted for one-time gains and costs, came to $2.31 per share. The results topped Wall Street expectations. The ...

  • Thermo Fisher Scientific Reports Third Quarter 2017 Results
    PR Newswire2 months ago

    Thermo Fisher Scientific Reports Third Quarter 2017 Results

    WALTHAM, Mass. , Oct. 25, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, today reported its financial results for the third quarter ended September ...

  • Winners of 2017 Nobel Prize in Chemistry Helped Spark "New Era" in Biochemistry
    PR Newswire2 months ago

    Winners of 2017 Nobel Prize in Chemistry Helped Spark "New Era" in Biochemistry

    Cryo-electron microscopes are used to "see the molecules inside the cell and how they interact" WALTHAM, Mass. , Oct. 6, 2017 /PRNewswire/ -- The 2017 Nobel Prize in Chemistry recognizes the ...

  • Barrons.com2 months ago

    [$$] Senate Health Funding Aids Thermo Fisher

    Follow Up: Expedia | Review | Preview Congress has blocked a bid by President Trump to slash funding for health research, and shares of laboratory equipment maker Thermo Fisher Scientific, are up nicely. ...

  • Market Realist2 months ago

    Thermo Fisher Scientific’s Recent System Launches

    Thermo Fisher Scientific continues to invest significantly in research and development as well as developing commercial capabilities, making the company one of the major medical technology players in the ...

  • Market Realist2 months ago

    TMO’s DNA Detection Kit Approved for FBI Use

    Thermo Fisher Scientific's Applied Biosystems DNA Kit (or Yfiler Plus PCR Amplification Kit) generates a CODIS (Combined DNA Index System) database.

  • Market Realist2 months ago

    Thermo Fisher Scientific: Why Wall Street Says ‘Buy’

    Let’s take a look at Wall Street analysts’ recommendations and 12-month target prices for Thermo Fisher Scientific (TMO).

  • Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 25, 2017
    PR Newswire3 months ago

    Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 25, 2017

    WALTHAM, Mass. , Sept. 28, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that it will release its financial results for the third quarter ...

  • MarketWatch3 months ago

    These life-science stocks provide biotech-like performance without the gyrations

    Life-science equipment-and-service providers have retuned as much as 60% this year. By Phil van Doorn.

  • Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V.
    PR Newswire3 months ago

    Thermo Fisher Scientific Completes Subsequent Offering Period of Tender Offer Following Acquisition of Patheon N.V.

    WALTHAM, Mass., Sept. 13, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, announced the expiration of the subsequent offering period of its previously announced tender offer to purchase all of the outstanding ordinary shares of Patheon N.V. The company completed the acquisition of Patheon on August 29, 2017. The subsequent offering period expired at 12:01 a.m., New York City time, on September 13, 2017. Based on information provided by American Stock Transfer & Trust Company, LLC, the depositary for the tender offer, a total of 143,781,162 Patheon ordinary shares (including Patheon ordinary shares tendered during the initial offering period), representing approximately 99% of the outstanding Patheon ordinary shares, had been validly tendered as of 12:01 a.m., New York City time, on September 13, 2017.

  • Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 11, 2017
    PR Newswire3 months ago

    Thermo Fisher Scientific to Present at the Morgan Stanley Global Healthcare Conference on September 11, 2017

    WALTHAM, Mass. , Sept. 5, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (NYSE: TMO), the world leader in serving science, announced that Marc N. Casper , president and chief executive officer, will ...

  • Thermo Fisher Scientific Completes Acquisition of Patheon
    PR Newswire4 months ago

    Thermo Fisher Scientific Completes Acquisition of Patheon

    WALTHAM, Mass., Aug. 29, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, announced that it has completed its acquisition of Patheon N.V. (PTHN), a leading contract development and manufacturing organization (CDMO) serving the pharmaceutical and biotechnology sectors, for approximately $7.2 billion. Today's close follows the expiration of Thermo Fisher's initial tender offer for Patheon at $35.00 per share in cash. "We're pleased to complete our acquisition of Patheon and look forward to the significant value this transaction will create for our customers and our shareholders," said Marc N. Casper, president and chief executive officer of Thermo Fisher Scientific.

  • Thermo Fisher Scientific Announces Receipt of All Required Regulatory Approvals for Proposed Acquisition of Patheon
    PR Newswire4 months ago

    Thermo Fisher Scientific Announces Receipt of All Required Regulatory Approvals for Proposed Acquisition of Patheon

    WALTHAM, Mass., Aug. 23, 2017 /PRNewswire/ -- Thermo Fisher Scientific Inc. (TMO), the world leader in serving science, announced that all required antitrust clearances have been obtained for the previously announced all-cash tender offer by its wholly owned subsidiary, Thermo Fisher (CN) Luxembourg S.à r.l., to purchase all of the outstanding ordinary shares of Patheon N.V. (PTHN). Competition authorities in Brazil approved the transaction on August 7, 2017, initiating a 15 calendar-day comment period, which expired on August 22, 2017. Additionally, the European Commission approved the transaction today.

  • Thermo Fisher Scientific Prices Offering of Senior Notes
    PR Newswire4 months ago

    Thermo Fisher Scientific Prices Offering of Senior Notes

    Thermo Fisher intends to use all of the net proceeds of the offering to fund a portion of the consideration payable for its acquisition of Patheon N.V. (PTHN), including the repayment of indebtedness of Patheon N.V. to be assumed by Thermo Fisher. As previously announced, Thermo Fisher now expects to complete the transaction around the end of the third quarter of 2017, subject to the satisfaction of customary closing conditions, including the receipt of applicable regulatory approvals and completion of Thermo Fisher's tender offer to acquire all of the issued and outstanding shares of Patheon N.V.